Clinical and Microbiologic Characteristics of Cephalosporin-Resistant E. Coli-PITT Protocol
The purpose of this study is to review patients with E. coli infections at UPMC from September 1, 2008 to August 31, 2010 to determine if these infections have arisen in the community rather than in hospitals or nursing homes and determine their clinical outcomes.
The specific aims of this study are to:
- Review whether cephalosporin-resistant E. coli infections are hospital-acquired, healthcare-associated or community-associated.
- Determine the clinical outcome of the patients according to the antibiotics given.
E Coli Infections
|Study Design:||Observational Model: Case Control
Time Perspective: Prospective
|Official Title:||Clinical and Microbiologic Characteristics of Cephalosporin-Resistant E. Coli-PITT Protocol|
- dead or alive [ Time Frame: end of study ] [ Designated as safety issue: No ]health status
Biospecimen Retention: Samples Without DNA
|Study Start Date:||March 2009|
|Estimated Study Completion Date:||December 2015|
|Estimated Primary Completion Date:||December 2015 (Final data collection date for primary outcome measure)|
Please refer to this study by its ClinicalTrials.gov identifier: NCT00877708
|United States, Pennsylvania|
|Pittsburgh, Pennsylvania, United States, 15213|
|Principal Investigator:||Yohei Doi, MD||UPMC|